ArticleOncogene2010

Inhibitors of HSP90 block p95-HER2 signaling in Trastuzumab-resistant tumors and suppress their growth.

S Chandarlapaty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.